Company news
Atlas Energy Corp. news in 2023
Atlas Energy Corp.'s news releases, calls and decks from 2023, newest first.
Willow Bioscience plans to advance development program with Nasdaq-listed company
December 11, 2023
Willow and leading innovative biopharmaceutical company advance development program to manufacture sustainable intermediates and active pharmaceutical ingredients
December 7, 2023
Willow biosciences reports third quarter 2023 financial results and provides corporate update
November 14, 2023
Willow biosciences announces completion of previously announced convertible debenture financing
October 10, 2023
Willow Bioscience teams again with Suanfarma on large volume anti-infective API
October 5, 2023
Willow and SUANFARMA announce collaboration on development of large volume anti-infective API through precision fermentation
October 3, 2023
Willow Bioscience eyes another use for BioOxi platform with R&D of ursodeoxycholic acid
September 12, 2023
Willow biosciences announces company insider led convertible debenture financing
September 12, 2023
Willow announces successful completion of R&D program on cost-effective, sustainably produced UDCA
September 6, 2023
Willow Bioscience files patent to help reduce costs of corticosteroids
September 4, 2023
Willow announces filing of patent application for process to produce corticosteroids at signficantly reduced cost
August 30, 2023
Willow Bioscience shifts focus to opportunity with BioOxi bio-oxidation platform
August 29, 2023
Willow biosciences announces commercial transition and focus on BioOxi platform
August 24, 2023
Willow announces collaboration with a leading innovative biopharmaceutical company to develop sustainable intermediates and active pharmaceutical ingredients
August 21, 2023
Willow biosciences reports second quarter 2023 financial results
August 8, 2023
Willow biosciences to present at the emerging growth conference on August 9
August 2, 2023
Willow and kalsec advance development program for new natural functional ingredient for savory foods
July 20, 2023
Willow biosciences to present at the emerging growth conference on June 14
June 7, 2023
Willow Bioscience agrees to partnership with biotech company looking at age-related diseases
June 2, 2023
Willow signs master services agreement with innovative biotech company to develop ingredients for age-related diseases
May 31, 2023
Kalsec and willow biosciences to develop novel enzyme for production of an advanced beverage ingredient
May 23, 2023
Willow biosciences reports first quarter 2023 results
May 11, 2023
Willow announces commercial agreement with sandhill one
April 18, 2023
Willow announces rollout of BioOxi platform providing valuable and expedited bioconversion-enabled chemical manufacturing
April 12, 2023
Willow biosciences announces changes to board and management
March 28, 2023
Willow & SUANFARMA announce completed development and manufacturing process for CBG and commitment to the production of new molecules in a natural way
March 22, 2023
Willow biosciences reports fourth quarter and fiscal year 2022 financials and operations and filing of its 2022 aif
March 21, 2023
Willow announces appointment of Dr. Jim Lalonde to board of directors
February 22, 2023
Willow announces follow-on engagement for next phase of partnered pharmaceutical project
January 17, 2023